Articles by William Looney - Pharmaceutical Executive

ADVERTISEMENT

Articles by William Looney

Less, But Better

Jul 1, 2012

Pharm Exec's 2012 roster of Emerging Leaders—our sixth to date—is not only a way to recognize a few individuals who've made a difference in their organizations. It also serves as a barometer to track larger changes in the workplace.

Today's Mission Critical: Making Sense of Spending on Clinical Trials

Jul 1, 2012

Mastery of the clinical trial process has become essential to positioning new therapies for leadership in an increasingly crowded—and lengthy—race to registration.

The Learning Curve

Jul 1, 2012

In a wake up call to this year's Emerging Leaders a group of St. Joseph's Business School Health Management alumni say time has no limit on surprises—change for pharma is here and its good.

2012 Dealmakers Outlook

Jun 1, 2012

Pharm Exec convened a panel of heavy hitters in business development to crack the bat on best practices in licensing and M&A for the year ahead.

From the Editor:The Connections Game

Jun 1, 2012

As the old Broadway song goes, June is busting out all over—and true to the season this month's issue stretches the seams with content that ranges from the sublime to the ridiculous.

Information Overload

May 1, 2012

Data has become as important as the drug in driving success in healthcare.

Pharma 50 Comment: Seeding Beyond the Base

May 1, 2012

The industry's reputation as a growth industry no one wants to pay for is more secure than ever, writes Pharm Exec Editor William Looney.

Succeeding in Pharma as a Woman or Minority Professional

Apr 24, 2012

Broaden your industry exposure. Think beyond yourself... Timely advice from this year's HBA Woman of the Year, Carolyn Buck Luce.

IP: Time for a Reset?

Apr 4, 2012

IP must adapt to new ways of extracting value from assets the industry never knew it had, writes William Looney.

ADVERTISEMENT

Click here